chr5-139364564-A-G
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_016480.5(PAIP2):āc.139A>Gā(p.Ile47Val) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000488 in 1,556,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016480.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PAIP2 | NM_016480.5 | c.139A>G | p.Ile47Val | missense_variant, splice_region_variant | 3/4 | ENST00000265192.9 | NP_057564.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PAIP2 | ENST00000265192.9 | c.139A>G | p.Ile47Val | missense_variant, splice_region_variant | 3/4 | 1 | NM_016480.5 | ENSP00000265192 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248448Hom.: 0 AF XY: 0.0000446 AC XY: 6AN XY: 134500
GnomAD4 exome AF: 0.0000470 AC: 66AN: 1404112Hom.: 0 Cov.: 24 AF XY: 0.0000499 AC XY: 35AN XY: 701892
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2024 | The c.139A>G (p.I47V) alteration is located in exon 3 (coding exon 2) of the PAIP2 gene. This alteration results from a A to G substitution at nucleotide position 139, causing the isoleucine (I) at amino acid position 47 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at